Acquired Glucose-6-Phosphate Dehydrogenase Deficiency

被引:10
作者
Pes, Giovanni Mario [1 ,2 ]
Dore, Maria Pina [1 ,3 ]
机构
[1] Univ Sassari, Clin Med, Dipartimento Med Chirurg & Farm, Viale San Pietro 8, I-07100 Sassari, Italy
[2] Sardinia Longev Blue Zone Observ, I-08040 Ogliastra, Italy
[3] Baylor Coll Med, Dept Med, One Baylor Plaza Blvd, Houston, TX 77030 USA
关键词
G6PD deficiency; acquired disease; oxidative stress; endocrinopathies; GLUTATHIONE REDOX STATUS; G6PD DEFICIENCY; DIABETIC-KETOACIDOSIS; PRIMARY CULTURES; MESSENGER-RNA; CARDIOVASCULAR-DISEASE; OXIDATIVE STRESS; IN-VIVO; INHIBITION; DEHYDROEPIANDROSTERONE;
D O I
10.3390/jcm11226689
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Glucose-6-phosphate dehydrogenase (G6PD) deficiency is a hereditary condition caused by mutations on chromosome X and is transmitted by a sex-linked inheritance. However, impairment of G6PD activity may result from biochemical mechanisms that are able to inhibit the enzyme in specific clinical conditions in the absence of a structural gene-level defect. In this narrative review, a number of clinical settings associated with an "acquired" G6PD deficiency, phenotypically undistinguishable from the primary deficiency, as well as the mechanisms involved, were examined. Hyperaldosteronism and diabetes are the most common culprits of acquired G6PD deficiency. Additional endocrine and metabolic conditions may cause G6PD deficiency in both hospitalized and outpatients. Contrary to the inherited defect, acquired G6PD deficiency is a condition that is potentially curable by removing the factor responsible for enzyme inhibition. Awareness regarding acquired G6PD deficiency by physicians might result in improved recognition and treatment.
引用
收藏
页数:12
相关论文
共 82 条
[1]   Glucose 6 phosphate dehydrogenase (GOD) deficiency is a possible risk factor for the development of preeclampsia [J].
Abdulhadi, NH .
MEDICAL HYPOTHESES, 2004, 62 (05) :780-782
[2]   Preeclampsia inactivates glucose-6-phosphate dehydrogenase and impairs the redox status of erythrocytes and fetal endothelial cells [J].
Afzal-Ahmed, Iram ;
Mann, Giovanni E. ;
Shennan, Andrew H. ;
Poston, Lucilla ;
Naftalin, Richard J. .
FREE RADICAL BIOLOGY AND MEDICINE, 2007, 42 (12) :1781-1790
[3]   Glucose 6 Phosphate Dehydrogenase Deficiency Unmasked by Diabetic Ketoacidosis: An Underrated Phenomenon [J].
Agarwal, Ayushi ;
Nayak, Deepak M. ;
Patil, Asha ;
Manohar, Chethan .
JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2013, 7 (12) :3012-3013
[4]   Glucose-6-phosphate dehydrogenase deficiency induced haemolysis in a woman with newly diagnosed diabetes after normalisation of hyperglycaemia [J].
ALjishi, F. ;
ALDarwish, M. .
DIABETIC MEDICINE, 2017, 34 (09) :1318-1321
[5]   Diabetic Ketoacidosis Revealing Severe Glucose-6-Phosphate Dehydrogenase Deficiency (G6PD-D) Deficiency with Methemoglobinemia: A Case Report [J].
Alzaki, Alaa A. ;
Alalawi, Noor H. .
AMERICAN JOURNAL OF CASE REPORTS, 2019, 20 :726-729
[6]   Diabetic Ketoacidosis Unmasking a Diagnosis of Glucose-6-Phosphate Dehydrogenase Deficiency: A Case Report and Literature Review [J].
Ansari, Umair ;
Bhardwaj, Puja ;
Quadri, Hamza ;
Barnes, Martin ;
George, Jerry .
CUREUS JOURNAL OF MEDICAL SCIENCE, 2022, 14 (04)
[7]  
ARNOLD H, 1977, BLOOD, V49, P1022
[8]   ACQUIRED RED-CELL ENZYME DEFECTS IN HEMATOLOGICAL DISEASES [J].
ARNOLD, H ;
BLUME, KG ;
LOHR, GW ;
BOULARD, M ;
NAJEAN, Y .
CLINICA CHIMICA ACTA, 1974, 57 (02) :187-189
[9]  
Au W. Y., 2009, Hong Kong Medical Journal, V15, P35
[10]   EFFECT OF PLASMA-LEVELS OF PARATHYROID-HORMONE ON NADPH PATHWAYS IN KIDNEY AND LIVER [J].
BACHELET, M ;
BOURDEAU, A ;
LAIR, M ;
BADER, C ;
BENNASR, L ;
THOMAS, M ;
ULMANN, A .
KIDNEY INTERNATIONAL, 1985, 27 (02) :401-404